BeiGene Ltd (BGNE)
176.50
+1.78
(+1.02%)
USD |
NASDAQ |
Dec 20, 16:00
177.10
+0.60
(+0.34%)
After-Hours: 20:00
BeiGene Total Liabilities (Quarterly): 2.395B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Theravance Biopharma Inc | 170.45M |
| Merck & Co Inc | 72.97B |
| Dr Reddy's Laboratories Ltd | 1.871B |
| Bristol-Myers Squibb Co | 76.47B |
| Zai Lab Ltd | 317.68M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.831B |
| Shareholders Equity (Quarterly) | 3.436B |
| Debt to Equity Ratio | 0.306 |
| Current Ratio | 1.931 |
| Net Debt Paydown Yield | -0.35% |